OTC Pink:RADCQ

Rite Aid and Bartell Drugs Host Monthly Immunization Days This Summer

Retrieved on:

Wednesday, May 1, 2024

General Health, Pharmaceutical, Health, Cold medicine, Aid, OTC, Shingles, Rite Aid, Immunization, COVID-19, Tetanus, Vaccine, RSV, Travel, HPV

Rite Aid (OTC: RADCQ) and Bartell Drugs will offer a monthly Family Immunization Day event from 10 a.m. to 6 p.m. the first Wednesday of each month, beginning May 1 through August 7 at select locations.

Key Points:

Rite Aid (OTC: RADCQ) and Bartell Drugs will offer a monthly Family Immunization Day event from 10 a.m. to 6 p.m. the first Wednesday of each month, beginning May 1 through August 7 at select locations.
Customers who are unable to attend an Immunization Day at a participating Immunization Day location can schedule an appointment for necessary vaccinations at their local Rite Aid through the online scheduling tool .
Bartell Drugs customers may use their online scheduler as well.
To help customers determine which routine immunizations are right for them, Rite Aid offers an Immunization Evaluation Questionnaire on its website.

Rite Aid Expands Partnership with Uber Eats to Deliver Alcohol in Additional Markets

Retrieved on:

Tuesday, April 30, 2024

Retail, Convenience Store, Food, Beverage, Wine & Spirits, Rite Aid, System, Wine, Uber Eats, Uber, Aid, OTC, City, Partnership, Rite, ID, Online shopping

Rite Aid (OTC: RADCQ) today announced the expansion of its delivery partnership with Uber Eats to include alcohol in new markets.

Key Points:

Rite Aid (OTC: RADCQ) today announced the expansion of its delivery partnership with Uber Eats to include alcohol in new markets.
“Our collaboration and trusted partnership with Uber Eats underscores our commitment to meeting the evolving needs of our customers and providing a seamless digital shopping experience that complements their busy lives,” said Jeanniey Walden, senior vice president and Chief Marketing Officer at Rite Aid.
“Through our expanded partnership with Rite Aid, we’re excited to continue to help consumers get more of what they want - all at the touch of a button.”
Adults of legal drinking age in select markets can visit ubereats.com or download the Uber Eats app to shop a range of alcohol brands from Rite Aid where available.
You are responsible for observing local laws on where you can consume or possess alcohol.

Rite Aid Becomes Copia’s First Retail Pharmacy Partner to Help Combat Food Waste and Support Communities

Retrieved on:

Tuesday, March 12, 2024

Department Stores, Supermarket, Philanthropy, Food, Beverage, Health, Pharmaceutical, General Health, Retail, Foundation, Rite Aid, Partnership, Communication, Corporate Affairs, Carbon, Methane, OTC, Donation, Aid

Rite Aid (OTC: RADCQ) today announced its partnership with food surplus tracking and donation platform Copia, as it furthers its efforts to reduce waste and make a meaningful impact in the California communities it serves.

Key Points:

Rite Aid (OTC: RADCQ) today announced its partnership with food surplus tracking and donation platform Copia, as it furthers its efforts to reduce waste and make a meaningful impact in the California communities it serves.
As the first retail pharmacy chain to partner with Copia, Rite Aid will donate food items leveraging Copia’s seamless surplus redistribution platform to easily track inventory, prove compliance, and record impact in real time.
The platform will match Rite Aid with local nonprofit organizations focused on combating food insecurity.
Food waste is one of the largest contributors to methane emissions from landfills, and by choosing to donate surplus, Rite Aid is reducing their impact on the planet,” said Kimberly Smith, CEO of Copia.

Rite Aid Enters into Agreement to Divest Majority of Health Dialog Assets

Retrieved on:

Wednesday, March 6, 2024

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced that it has entered into an asset purchase agreement (“APA”) for the partial sale of its Health Dialog business to Carenet Health (“Carenet”), a provider of healthcare engagement, clinical support, telehealth and advocacy solutions.

Key Points:

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced that it has entered into an asset purchase agreement (“APA”) for the partial sale of its Health Dialog business to Carenet Health (“Carenet”), a provider of healthcare engagement, clinical support, telehealth and advocacy solutions.
Health Dialog provides personalized population health solutions to improve the health of members while reducing overall medical costs for companies and organizations.
Rite Aid is integrating these into the Company’s clinical offerings.
Mr. Stein added, “Health Dialog’s clients and members will be in terrific hands with Carenet, which is a pioneer and industry leader in personalized healthcare engagement solutions.

Rite Aid and Bartell Drugs Announce Additional Dose of Updated COVID-19 Vaccine Available for Customers Ages 65 and Older

Retrieved on:

Tuesday, March 5, 2024

Retail, Health, Convenience Store, COVID-19, Specialty, General Health, Pharmaceutical, OTC, Rite Aid, Vaccination, ACIP, Aid, Senior, Pharmacist, CDC, Pacific Northwest, Vaccine

Rite Aid (OTC:RADCQ) recently announced that appointments are now available for eligible customers ages 65 and older seeking an additional dose of the updated COVID-19 (2023-2024) vaccines at its locations, including Bartell Drugs locations in the Pacific Northwest.

Key Points:

Rite Aid (OTC:RADCQ) recently announced that appointments are now available for eligible customers ages 65 and older seeking an additional dose of the updated COVID-19 (2023-2024) vaccines at its locations, including Bartell Drugs locations in the Pacific Northwest.
“Rite Aid wants to ensure our customers safeguard their health, especially those in vulnerable populations, including our customers ages 65 and older.”
The updated COVID-19 vaccine provides enhanced protection against currently circulating variants of COVID-19.
According to the new recommendation, all customers ages 65 and older who previously received the COVID-19 vaccine (2023-2024) should receive an additional dose four months after receipt of the prior dose.
Rite Aid pharmacists are trained to immunize customers ages three and older based on the CDC's vaccine guidelines and state regulations.

Rite Aid Unveils New ‘It Means More’ Ad Spot, Showcasing Unwavering Commitment to Serving and Supporting Its Customers

Retrieved on:

Thursday, February 22, 2024

Food, Beverage, Other Retail, Discount, Variety, Retail, Specialty, Cream, Rite Aid, System, Health, Heart, Multimedia, Thrifty PayLess, Tourism

Today, Rite Aid debuted its new ‘It Means More’ ad – spotlighting the retail pharmacy chain's commitment to its customers, together with the passion and ongoing dedication of its employees to continuously provide unrivaled customer experiences.

Key Points:

Today, Rite Aid debuted its new ‘It Means More’ ad – spotlighting the retail pharmacy chain's commitment to its customers, together with the passion and ongoing dedication of its employees to continuously provide unrivaled customer experiences.
Their expertise and unwavering commitment continuously make a meaningful impact in the lives of customers, inspiring them to entrust Rite Aid with their whole health needs every day.
"Putting our customers first by creating authentic relationships is what differentiates Rite Aid in the retail pharmacy space," said Jeanniey Walden, Chief Marketing Officer at Rite Aid.
“‘It Means More’ is a testament to the exceptional service that our employees consistently deliver and the genuine connections they have with our customers.

Rite Aid Completes Sale of Elixir Solutions to MedImpact

Retrieved on:

Thursday, February 1, 2024

General Health, Pharmaceutical, Health, Other Health, Rite Aid, Kirkland & Ellis, Sale, Guggenheim Partners, OTC, Alvarez and Marsal, LLP, Rite

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced it has completed the previously announced sale of its Elixir Solutions business (“Elixir”) to MedImpact Healthcare Systems, Inc. (“MedImpact”) for approximately $575 million.

Key Points:

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced it has completed the previously announced sale of its Elixir Solutions business (“Elixir”) to MedImpact Healthcare Systems, Inc. (“MedImpact”) for approximately $575 million.
“We are pleased to finalize the sale of Elixir, marking another important milestone in our transformation to strengthen our long-term financial position,” said Jeffrey S. Stein, Rite Aid’s CEO and Chief Restructuring Officer.
“We believe this transaction is a great outcome for Rite Aid and our stakeholders, including our Elixir colleagues and the customers, clients and members they serve.
Importantly, this divestiture will better position Rite Aid for long-term success as we continue to evolve our portfolio to focus on the healthcare products, services and solutions that are core to our future.”
Rite Aid provides leading healthcare products and services to its customers every day as it continues to make progress in its court-supervised restructuring process and implement its go-forward business plan, Rite Aid 2.0.

Find Your ‘Perfect Pairing’ at Rite Aid this Valentine's Day

Retrieved on:

Tuesday, January 30, 2024

Love is in the air, and Rite Aid is ready to make this Valentine’s Day unforgettable.

Key Points:

Love is in the air, and Rite Aid is ready to make this Valentine’s Day unforgettable.
View the full release here: https://www.businesswire.com/news/home/20240130312401/en/
This Valentine’s Day Rite Aid is playing matchmaker — for your tastebuds!
Set the scene for a day of love, whether it’s with your sweetheart, friends or little ones, with Rite Aid's enchanting selection of Valentine's Day decorations.
Explore all of Rite Aid’s Valentine’s Day offerings at www.riteaid.com/shop/valentine-s-day or head to your local store for special in-store-only selections.

Rite Aid Receives Court Approval for Sale of Elixir Solutions Business to MedImpact

Retrieved on:

Tuesday, January 9, 2024

Professional Services, Retail, Health, Other Retail, Finance, General Health, Pharmaceutical, Rite Aid, Guggenheim Partners, LLP, Kirkland & Ellis, Bankruptcy, Sale, Pharmacy, Rite, United States bankruptcy court, OTC, Alvarez and Marsal, Pharmaceutical industry

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced that the U.S. Bankruptcy Court for the District of New Jersey has approved the sale of the Company’s Elixir Solutions Business to MedImpact Healthcare Systems, Inc. (“MedImpact”), an independent pharmacy benefit solutions company.

Key Points:

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced that the U.S. Bankruptcy Court for the District of New Jersey has approved the sale of the Company’s Elixir Solutions Business to MedImpact Healthcare Systems, Inc. (“MedImpact”), an independent pharmacy benefit solutions company.
“We are pleased to receive this key approval toward the sale of our Elixir business to MedImpact,” said Jeffrey S. Stein, Rite Aid’s CEO and Chief Restructuring Officer.
“We are confident the transaction with MedImpact maximizes the value of the business and best positions Elixir to support clients, members and customers long into the future.
Until closing, Elixir remains part of Rite Aid and will continue operating as normal.

Rite Aid Reaches Settlement with FTC

Retrieved on:

Tuesday, December 19, 2023

Retail, Convenience Store, Facial recognition, Bankruptcy, LLP, Rite Aid, Alvarez and Marsal, Risk, Privacy, FTC, Kirkland & Ellis, Safety, OTC, Guggenheim Partners, Security (finance)

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced it has reached a comprehensive settlement agreement with the U.S. Federal Trade Commission (“FTC”) regarding the Company’s historical use of facial recognition technology to prevent retail theft and issues relating to the Company’s compliance with a 2010 Commission Order.

Key Points:

Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced it has reached a comprehensive settlement agreement with the U.S. Federal Trade Commission (“FTC”) regarding the Company’s historical use of facial recognition technology to prevent retail theft and issues relating to the Company’s compliance with a 2010 Commission Order.
The Company issued the following statement:
“We are pleased to reach an agreement with the FTC and put this matter behind us.
Rite Aid stopped using the technology in this small group of stores more than three years ago, before the FTC’s investigation regarding the Company’s use of the technology began.
The settlement with the FTC is subject to approval by the U.S. Bankruptcy Court overseeing Rite Aid’s ongoing restructuring and the U.S. Federal District Court in which the FTC filed its complaint.